corner
Healthy Skepticism
Join us to help reduce harm from misleading health information.
Increase font size   Decrease font size   Print-friendly view   Print
Register Log in

Healthy Skepticism Library item: 12271

Warning: This library includes all items relevant to health product marketing that we are aware of regardless of quality. Often we do not agree with all or part of the contents.

 

Publication type: media release

Frontline Examines Why MoreThan 6 Million American Children Are Taking Powerful Psychiatric Drugs; Frontline Presents: The Medicated Child
PBS.org 2008 Jan 8
http://www.pbs.org/wgbh/pages/frontline/medicatedchild/


Full text:

Ten years ago, stimulants like Ritalin and Adderall were the drugs of choice to treat behavioral issues in children. Today, children as young as four years old are being prescribed more powerful anti-psychotic medications that are much less understood. The drugs can cause serious side effects and virtually nothing is known about their long-term impact.

The increase in the use of anti-psychotics is directly tied to the rising incidence of one particular diagnosis – bipolar disorder. Experts estimate that the number of kids with the diagnosis is now over a million and rising.

In recent years, there’s been a dramatic increase in the number of children being diagnosed with serious psychiatric disorders and prescribed medications that are just beginning to be tested in children. The drugs can cause serious side effects, and virtually nothing is known about their long-term impact. “It’s really to some extent an experiment, trying medications in these children of this age,” child psychiatrist Dr. Patrick Bacon tells FRONTLINE. “It’s a gamble. And I tell parents there’s no way to know what’s going to work.”

In The Medicated Child, airing Tuesday, January 8, 2008, at 9 P.M. ET on PBS (check local listings), FRONTLINE producer Marcela Gaviria confronts psychiatrists, researchers and government regulators about the risks and benefits of prescription drugs for troubled children. The biggest current controversy surrounds the diagnosis of bipolar disorder. Formerly called manic depression, bipolar disorder was long believed to exist only in adults, but, in the mid-1990s, bipolar in children began to be diagnosed at much higher rates, sometimes in kids as young as 4 years old. “The rates of bipolar diagnoses in children have increased markedly in many communities over the last five to seven years,” says Dr. Steven Hyman, a former director of the National Institute of Mental Health. “I think the real question is, are those diagnoses right? And in truth, I don’t think we yet know the answer.”

Like many of the 1 million children now diagnosed with bipolar, 5-year-old Jacob Solomon was initially believed to suffer from an attention deficit disorder. His parents reluctantly started him on Ritalin, but over the next five years, Jacob would be put on one drug after another. “It all started to feel out of control,” Jacob’s father, Ron, told FRONTLINE. “Nobody ever said we can work with this through therapy and things like that. Everywhere we looked it was, ‘Take meds, take meds, take meds.’”

Over the years, Jacob’s multiple medications have helped improve his mood, but they’ve also left him with a severe tic in his neck which doctors are having trouble fully explaining. “We’re dealing with developing minds and brains, and medications have a whole different impact in the young developing child than they do in an adult,” says Dr. Marianne Wamboldt, the chief of psychiatry at Denver Children’s Hospital. “We don’t understand that impact very well. That’s where we’re still in the Dark Ages.”

DJ Koontz was diagnosed with bipolar at 4 years old, after his temper tantrums became more frequent and explosive. He was recently prescribed powerful antipsychotic drugs. “It is a little worrisome to me because he is so young,” says DJ’s mother, Christine. “If he didn’t take it, though, I don’t know if we could function as a family. It’s almost a do-or-die situation over here.” DJ’s medicines seem to be helping him in the short run, but the longer-term outlook is still uncertain. “What’s not really clear is whether many of the kids who are called bipolar have anything that’s related to this very well-studied disorder in adults,” says Thomas Insel, the director of the National Institute for Mental Health. “It’s not clear that people with that adult illness started with what we’re now calling bipolar in children. Nor is it clear that the kids who have this disorder are going to grow up to have what we used to call manic-depressive illness in adulthood.”

While some urge caution when it comes to bipolar in children, FRONTLINE talks with others who argue that we should intervene with drug treatments at even younger ages for children genetically predisposed to the disorder. “The theory is that if you get in early, before the first full mood episode, then perhaps we can delay the onset to full mania,” says Dr. Kiki Chang of Stanford University. “And if that’s the case, perhaps finding the right medication early on can protect a brain so that these children never do progress to full bipolar disorder.”

FRONTLINE’s 2001 documentary Medicating Kids can be watched online at www.pbs.org/frontline/shows/medicating

The Medicated Child is a FRONTLINE co-production with RAINMedia, Inc. The writer and producer is Marcela Gaviria. The co-producer is Will Cohen.
FRONTLINE is produced by WGBH Boston and is broadcast nationwide on PBS.
Funding for FRONTLINE is provided through the support of PBS viewers. Major funding for FRONTLINE is provided by The John D. and Catherine T. MacArthur Foundation. Additional funding is provided by the Park Foundation. FRONTLINE is closed-captioned for deaf and hard-of-hearing viewers and described for people who are blind or visually impaired by the Media Access Group at WGBH.
FRONTLINE is a registered trademark of WGBH Educational Foundation. The executive producer of FRONTLINE is David Fanning.

pbs.org/pressroom
Promotional photography can be downloaded from the PBS pressroom.

Press contacts
Diane Buxton
(617) 300-5375
diane_buxton@wgbh.org

Alissa Rooney
(617) 300-5314
alissa_rooney@wgbh.org

Phil Zimmerman
(617) 300-5366
phil_zimmerman@wgbh.org

 

  Healthy Skepticism on RSS   Healthy Skepticism on Facebook   Healthy Skepticism on Twitter

Please
Click to Register

(read more)

then
Click to Log in
for free access to more features of this website.

Forgot your username or password?

You are invited to
apply for membership
of Healthy Skepticism,
if you support our aims.

Pay a subscription

Support our work with a donation

Buy Healthy Skepticism T Shirts


If there is something you don't like, please tell us. If you like our work, please tell others.

Email a Friend








What these howls of outrage and hurt amount to is that the medical profession is distressed to find its high opinion of itself not shared by writers of [prescription] drug advertising. It would be a great step forward if doctors stopped bemoaning this attack on their professional maturity and began recognizing how thoroughly justified it is.
- Pierre R. Garai (advertising executive) 1963